Comparing biote (NASDAQ:BTMD) and MariMed (OTCMKTS:MRMD)

biote (NASDAQ:BTMDGet Rating) and MariMed (OTCMKTS:MRMDGet Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

Profitability

This table compares biote and MariMed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
biote N/A -52.44% 8.28%
MariMed 1.27% 4.02% 1.27%

Analyst Recommendations

This is a summary of recent ratings and target prices for biote and MariMed, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
biote 0 0 3 0 3.00
MariMed 0 0 2 0 3.00

biote presently has a consensus price target of $10.33, indicating a potential upside of 163.61%. Given biote’s higher possible upside, analysts clearly believe biote is more favorable than MariMed.

Valuation and Earnings

This table compares biote and MariMed’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
biote N/A N/A $11.11 million N/A N/A
MariMed $121.46 million 1.26 $7.22 million N/A N/A

biote has higher earnings, but lower revenue than MariMed.

Insider & Institutional Ownership

2.1% of biote shares are held by institutional investors. Comparatively, 0.3% of MariMed shares are held by institutional investors. 20.0% of MariMed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

biote has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, MariMed has a beta of 3.35, indicating that its share price is 235% more volatile than the S&P 500.

About biote

(Get Rating)

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

About MariMed

(Get Rating)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.